Oral fosfomycin for treatment of acute bacterial prostatitis caused by multidrug-resistant Enterobacterales

To assess the feasibility of oral fosfomycin-tromethamine (FT) for the management of acute bacterial prostatitis (ABP) caused by multidrug-resistant (MDR) Enterobacterales. An observational study of adult patients diagnosed with ABP from Vall d’Hebron University Hospital (Barcelona, Spain), treated...

Descripción completa

Detalles Bibliográficos
Autores principales: Burgos, Joaquin, Hoyos-Mallecot, Yannick, Ferre-Losa, Carles, Arando, Maider, Monforte, Arnau, Pumarola, Tomas, Los-Arcos, Ibai, Falcó, Vicenç
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10580941/
https://www.ncbi.nlm.nih.gov/pubmed/37737627
http://dx.doi.org/10.1128/spectrum.02136-23

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10580941/
https://www.ncbi.nlm.nih.gov/pubmed/37737627
http://dx.doi.org/10.1128/spectrum.02136-23

Ejemplares similares